Fresenius Medical Care AG (FMS:NYSE) closed at $22.68 on October 23, 2026, up 2.02% on the day. The stock trades 17.2% below its 52-week high of $27.40 and 13.3% above its 52-week low of $20.02. Over the past year, it lost 16.7%. Fresenius Medical Care AG is part of the Health Care sector (Misc Health and Biotechnology Services).
In 252 trading sessions since October 23, 2025, FMS closed higher on 127 days (50%). Its best day was June 4, 2026 (+4.93%) and its worst was May 5, 2026 (-10.86%). The stock moved 10% or more in a single session 1 time.
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure. The company also develops, manufactures, and distributes dialysis products, including hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, and water treatment systems for the treatment of ESRD; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, and endovascular specialty, as well as hospitalist and intensivist, and medical cost management services. In addition, it develops, acquires, and in-licenses renal pharm...
Find more stocks like FMS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.